Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-01-21 @ 12:20 PM
Study NCT ID:
NCT05742269
Status:
RECRUITING
Last Update Posted:
2025-02-26
First Post:
2023-01-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast Cancer
Sponsor:
Karolinska University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-17
First Submit QC Date:
None
Study First Post Date:
2023-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-24
Last Update Post Date:
2025-02-26
Last Update Post Date Type:
ACTUAL